The HER4 cytoplasmic domain, but not its C terminus, inhibits mammary cell proliferation

Molecular Endocrinology

Volumn 21, Issue 8, 2007, Pages 1861-1876

  Feng, Shu Mang ^a   Sartor, Carolyn I ^a   Hunter, Debra ^a   Zhou, Hong ^a   Yang, Xihui ^a   Caskey, Laura S ^a   Dy, Ruth ^a   Muraoka Cook, Rebecca S ^a   Earp III, H Shelton ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 4; GAMMA SECRETASE; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; STAT5A PROTEIN;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

AMYLOID PRECURSOR PROTEIN SECRETASES; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOPLASM; FEMALE; GROWTH INHIBITORS; HUMANS; MAMMARY GLANDS, HUMAN; NEUREGULIN-1; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 34547450199     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2006-0101     Document Type: Article

References (57)

1. Lacenere CJ, Sternberg PW 2000 Regulation of EGF receptor signaling in the fruitfly D. melanogaster and the nematode C. elegans. Breast Dis 11:19-30
2. Yarden Y, Sliwkowski MX 2001 Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2:127-137
3. Earp III HS, Calvo BF, Sartor CI 2003 The EGF receptor family - multiple roles in proliferation, differentiation, and neoplasia with an emphasis on HER4. Trans Am Clin Climatol Assoc 114:315-333
4. Roskoski Jr R 2004 The ErbB/HER receptor protein-tyrosine kinases and cancer. Biochem Biophys Res Commun 319:1-11
5. Holbro T, Hynes NE 2004 ErbB receptors: directing key signaling networks throughout life. Annu Rev Pharmacol Toxicol 44:195-217
6. Stern DF 2003 ErbBs in mammary development. Exp Cell Res 284:89-98
7. Schroeder JA, Lee DC 1998 Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland. Cell Growth Differ 9:451-464
8. Troyer KL, Lee DC 2001 Regulation of mouse mammary gland development and tumorigenesis by the ERBB signaling network. J Mammary Gland Biol Neoplasia 6:7-21
9. Tidcombe H, Jackson-Fisher A, Mathers K, Stern DF, Gassmann M, Golding JP 2003 Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality. Proc Natl Acad Sci USA 100:8281-8286
10. Hynes NE, Lane HA 2005 ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer. 5:341-354
11. Plowman GD, Culouscou JM, Whitney GS, Green JM, Carlton GW, Foy L, Neubauer MG, Shoyab M 1993 Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci USA 90:1746-1750
12. Gullick WJ 2003 c-erbB-4/HER4: friend or foe? J Pathol 200:279-281
13. Pawlowski V, Revillion F, Hebbar M, Hornez L, Peyrat JP 2000 Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res 6:4217-4225
14. Suo Z, Risberg B, Kalsson MG, Willman K, Tierens A, Skovlund E, Nesland JM 2002 EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival. J Pathol 196:17-25
15. Witton CJ, Reeves JR, Going JJ, Cooke TG, Bartlett JM 2003 Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer. J Pathol 200:290-297
16. Barnes NL, Khavari S, Boland GP, Cramer A, Knox WF, Bundred NJ 2005 Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast. Clin Cancer Res 11:2163-2168
17. Lodge AJ, Anderson JJ, Gullick WJ, Haugk B, Leonard RC, Angus B 2003 Type 1 growth factor receptor expression in node positive breast cancer: adverse prognostic significance of c-erbB-4. J Clin Pathol 56:300-304
18. Bieche I, Onody P, Tozlu S, Driouch K, Vidaud M, Lidereau R 2003 Prognostic value of ERBB family mRNA expression in breast carcinomas. Int J Cancer 106: 758-765
19. Elenius K, Corfas G, Paul S, Choi CJ, Rio C, Plowman GD, Klagsbrun M 1997 A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester. J Biol Chem 272:26761-26768
20. Elenius K, Choi CJ, Paul S, Santiestevan E, Nishi E, Klagsbrun M 1999 Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase. Oncogene 18:2607-2615
21. Junttila TT, Sundvall M, Maatta JA, Elenius K 2000 Erbb4 and its isoforms: selective regulation of growth factor responses by naturally occurring receptor variants. Trends Cardiovasc Med 10:304-310
22. Rio C, Buxbaum JD, Peschon JJ, Corfas G 2000 Tumor necrosis factor-α-converting enzyme is required for cleavage of erbB4/HER4. J Biol Chem 275:10379-10387
23. Cheng QC, Tikhomirov O, Zhou W, Carpenter G 2003 Ectodomain cleavage of ErbB-4: characterization of the cleavage site and m80 fragment. J Biol Chem 278: 38421-38427
24. Ebinu JO, Yankner BA 2002 A RIP tide in neuronal signal transduction. Neuron 34:499-502
25. Ni CY, Murphy MP, Golde TE, Carpenter G 2001 γ-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 294:2179-2181
26. Peles E, Bacus SS, Koski RA, Lu HS, Wen D, Ogden SG, Levy RB, Yarden Y 1992 Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells. Cell 69:205-216
27. Bacus SS, Huberman E, Chin D, Kiguchi K, Simpson S, Lippman M, Lupu R 1992 A ligand for the erbB-2 oncogene product (gp30) induces differentiation of human breast cancer cells. Cell Growth Differ 3:401-411
28. Bacus SS, Gudkov AV, Zelnick CR, Chin D, Stern R, Stancovski I, Peles E, Ben-Baruch N, Farbstein H, Lupu R, Wen D, Sela M, Yarden Y 1993 Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors. Cancer Res 53:5251-5261
29. Culouscou JM, Plowman GD, Carlton GW, Green JM, Shoyab M 1993 Characterization of a breast cancer cell differentiation factor that specifically activates the HER4/p180erbB4 receptor. J Biol Chem 268:18407-18410
30. Daly JM, Jannot CB, Beerli RR, Graus-Porta D, Maurer FG, Hynes NE 1997 Neu differentiation factor induces ErbB2 down-regulation and apoptosis of ErbB2-overexpressing breast tumor cells. Cancer Res 57:3804-3811
31. Sartor CI, Zhou H, Kozlowska E, Guttridge K, Kawata E, Caskey L, Harrelson J, Hynes N, Ethier S, Calvo B, Earp HS, 3rd 2001 Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells. Mol Cell Biol 21:4265-4275
32. Long W, Wagner KU, Lloyd KC, Binart N, Shillingford JM, Hennighausen L, Jones FE 2003 Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5. Development 130:5257-5268
33. Tang CK, Concepcion XZ, Milan M, Gong X, Montgomery E, Lippman ME 1999 Ribozyme-mediated down-regulation of ErbB-4 in estrogen receptor-positive breast cancer cells inhibits proliferation both in vitro and in vivo. Cancer Res 59:5315-5322
34. Alaoui-Jamali MA, Song DJ, Benlimame N, Yen L, Deng X, Hernandez-Perez M, Wang T 2003 Regulation of multiple tumor microenvironment markers by overexpression of single or paired combinations of ErbB receptors. Cancer Res 63:3764-3774
35. Maatta JA, Sundvall M, Junttila TT, Peri L, Laine VJ, Isola J, Egeblad M, Elenius K 2006 Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth. Mol Biol Cell. 17:67-79
36. Srinivasan R, Gillett CE, Barnes DM, Gullick WJ 2000 Nuclear expression of the c-erbB-4/HER-4 growth factor receptor in invasive breast cancers. Cancer Res 60: 1483-1487
37. Junttila TT, Sundvall M, Lundin M, Lundin J, Tanner M, Harkonen P, Joensuu H, Isola J, Elenius K 2005 Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells. Cancer Res 65:1384-1393
38. Marambaud P, Shioi J, Serban G, Georgakopoulos A, Sarner S, Nagy V, Baki L, Wen P, Efthimiopoulos S, Shao Z, Wisniewski T, Robakis NK 2002 A presenilin-1/γ-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J 21:1948-1956
39. Okamoto I, Kawano Y, Murakami D, Sasayama T, Araki N, Miki T, Wong AJ, Saya H 2001 Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. J Cell Biol 155:755-762
40. Kim DY, Ingano LA, Kovacs DM 2002 Nectin-1α, an immunoglobulin-like receptor involved in the formation of synapses, is a substrate for presenilin/γ-secretase-like cleavage. J Biol Chem 277:49976-49981
41. Schulz JG, Annaert W, Vandekerckhove J, Zimmermann P, De Strooper B, David G 2003 Syndecan 3 intramembrane proteolysis is presenilin/γ- secretase-dependent and modulates cytosolic signaling. J Biol Chem 278: 48651-48657
42. Komuro A, Nagai M, Navin NE, Sudol M 2003 WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus. J Biol Chem 278:33334-33341
43. Lin SY, Makino K, Xia W, Matin A, Wen Y, Kwong KY, Bourguignon L, Hung MC 2001 Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 3:802-808
44. Wang SC, Lien HC, Xia W, Chen IF, Lo HW, Wang Z, Ali-Seyed M, Lee DF, Bartholomeusz G, Ou-Yang F, Giri DK, Hung MC 2004 Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell 6:251-261
45. Muraoka-Cook RS, Caskey LS, Sandahl MA, Hunter DM, Husted C, Strunk KE, Sartor CI, Rearick WA, Jr., McCall W, Sgagias MK, Cowan KH, Earp HS, 3rd 2006 Heregulin-dependent delay in mitotic progression requires HER4 and BRCA1. Mol Cell Biol. 26:6412-6424
46. Zhou W, Carpenter G 2000 Heregulin-dependent trafficking and cleavage of ErbB-4. J Biol Chem 275: 34737-34743
47. Lee HJ, Jung KM, Huang YZ, Bennett LB, Lee JS, Mei L, Kim TW 2002 Presenilin-dependent γ-secretase-like intramembrane cleavage of ErbB4. J Biol Chem 277:6318-6323
48. Vecchi M, Baulida J, Carpenter G 1996 Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation. J Biol Chem 271:18989-18995
49. Linggi B, Cheng QC, Rao AR, Carpenter G 2006 The ErbB-4 s80 intracellular domain is a constitutively active tyrosine kinase. Oncogene. 25:160-163
50. Muraoka-Cook RS, Sandahl M, Husted C, Hunter D, Miraglia L, Feng SM, Elenius K, Earp III HS 2006 The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells. Mol Biol Cell 17:4118-4129
51. Fabian MA, Biggs III WH, Treiber DK, Atteridge CE, Azimioara MD, Benedetti MG, Carter TA, Ciceri P, Edeen PT, Floyd M, Ford JM, Galvin M, Gerlach JL, Grotzfeld RM, Herrgard S, Insko DE, Insko MA, Lai AG, Lelias JM, Mehta SA, Milanov ZV, Velasco AM, Wodicka LM, Patel HK, Zarrinkar PP, Lockhart DJ 2005 A small molecule-kinase interaction map for clinical kinase inhibitors. Nat Biotechnol 23:329-336
52. Jones FE, Welte T, Fu XY, Stern DF 1999 ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation. J Cell Biol 147:77-88
53. Williams CC, Allison JG, Vidal GA, Burow ME, Beckman BS, Marrero L, Jones FE 2004 The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone. J Cell Biol 167: 469-478
54. Vidal GA, Naresh A, Marrero L, Jones FE 2005 Presenilin-dependent γ-secretase processing regulates multiple ERBB4/HER4 activities. J Biol Chem 280:19777-19783
55. Cohen BD, Kiener PA, Green JM, Foy L, Fell HP, Zhang K 1996 The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells. J Biol Chem 271:30897-30903
56. Heldin CH, Ericsson J 2001 Signal transduction. RIPping tyrosine kinase receptors apart. Science 294:2111-2113
57. O'Keefe K, Li H, Zhang Y 2003 Nucleocytoplasmic shuttling of p53 is essential for MDM2-mediated cytoplasmic degradation but not ubiquitination. Mol Cell Biol. 23: 6396-6405